HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Halpern, E. J. Articles by Gomella, L. G. Search for Related Content PubMed PubMed Citation Articles by Halpern, E. J. Articles by Gomella, L. G. Social Bookmarking                      What's this?

Directed Biopsy During Contrast-Enhanced Sonography of the Prostate

¹ Department of Radiology, Jefferson Prostate Diagnostic Center, Thomas Jefferson University, 132 S. 10th St., Philadelphia, PA 19107-5244.
² Bristol-Myers Squibb Medical Imaging, 331 Treble Cove Rd., N., Billerica, MA 01862.
³ Department of Urology, Jefferson Prostate Diagnostic Center, Thomas Jefferson University, Philadelphia, PA 19107-5244.

OBJECTIVE. We evaluated the value of directed biopsy for the detection of prostate cancer during contrast-enhanced endorectal sonography.

SUBJECTS AND METHODS. Forty patients were evaluated with harmonic gray-scale sonography. The evaluation was performed before administration of contrast agent, during continuous IV infusion of perflutren lipid microspheres, and again during bolus administration of the microspheres. Sextant biopsy sites were scored prospectively on a six-point scale for suggestion of malignancy at baseline during contrast infusion and after bolus administration. An additional directed core was obtained at 20 of the sextant biopsy sites based on contrast-enhanced imaging.

RESULTS. Cancer was identified in 30 biopsy sites in 16 of the patients (40%). A suspicious site identified during contrast-enhanced transrectal sonography was 3.5 times more likely to have positive biopsy findings at than an adjacent site that was not suggestive of malignancy (p < 0.025). When a suspicious site was evaluated with an additional biopsy core, the site was five times more likely to have a biopsy with positive findings than a standard sextant site (p < 0.01). We found no difference in diagnostic accuracy between continuous infusion of contrast material and bolus administration.

CONCLUSION. Contrast-enhanced transrectal sonography improves the sonographic detection of malignant foci in the prostate. The performance of multiple biopsies of suspicious enhancing foci significantly improves the detection of cancer. There is no advantage to additional examination of the gland after bolus administration of contrast material.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. S. Adler, S. Fealy, J. R. Rudzki, W. Kadrmas, N. N. Verma, A. Pearle, S. Lyman, and R. F. Warren Rotator Cuff in Asymptomatic Volunteers: Contrast-enhanced US Depiction of Intratendinous and Peritendinous Vascularity Radiology, September 1, 2008; 248(3): 954 - 961. [Abstract] [Full Text] [PDF]

				A. Yi, J. K. Kim, S. H. Park, K. W. Kim, H. S. Kim, J. H. Kim, H. W. Eun, and K.-S. Cho Contrast-Enhanced Sonography for Prostate Cancer Detection in Patients with Indeterminate Clinical Findings. Am. J. Roentgenol., May 1, 2006; 186(5): 1431 - 1435. [Abstract] [Full Text] [PDF]

				D. Beyersdorff, A. Winkel, B. Hamm, S. Lenk, S. A. Loening, and M. Taupitz MR Imaging-guided Prostate Biopsy with a Closed MR Unit at 1.5 T: Initial Results Radiology, February 1, 2005; 234(2): 576 - 581. [Abstract] [Full Text] [PDF]

				P. H. Arger, S. B. Malkowicz, K. N. VanArsdalen, C. M. Sehgal, A. Holzer, and S. M. Schultz Color and Power Doppler Sonography in the Diagnosis of Prostate Cancer: Comparison Between Vascular Density and Total Vascularity J. Ultrasound Med., May 1, 2004; 23(5): 623 - 630. [Abstract] [Full Text] [PDF]